STAAR Surgical (STAA) - EV/EBITDA Multiple

STAAR Surgical Co - graphic logo of issuer STAA

The EV/EBITDA multiple trajectory illustrates the valuation dynamics of STAAR Surgical Company (STAA), where 34.41 represents the current value of the metric. STAAR Surgical Company (STAA) implements EVO ICL biocompatible implants as an alternative to laser vision correction. The production cycle is based on sterile manufacturing facilities in Switzerland and the US. Business stability is guaranteed by a dedicated staff of optical engineers, ensuring the expansion of global sales without the loss of key personnel.

STAA STAAR Surgical Corp: Enterprise Value to Operating Income Before Depreciation in the range 11/23/2025 - 11/14/2026

Analytical breakdowns for staar.com (STAA)

- stock price and consensus target price:
Stock Quotes STAAR Surgical Corp|STAA - Fair Value Consensus
- market capitalization indicators:
Market Capitalization STAAR Surgical Co|STAA - Company Buyout Price
- issuer book value statistics:
Net Assets per Single Share STAAR Surgical|STAA - Accounting Capitalization|Market Value to Book Value Ratio staar.com|STAA - Company Total Asset Base
- company liabilities and liquidity data:
Total Debt to Equity Ratio STAAR Surgical Company|STAA - Long-Term Loans to Capital Ratio|Short-Term Debt to Equity STAAR Surgical|STAA - Aggregate Debt Obligations|Debt to Book Value STAAR Surgical Co|STAA - Company Long-Term Debts|Company Short-Term Debt STAAR Surgical|Quick Ratio staar.com
- business earnings and investment ratios data:
STAA - Company Net Income|Expected Profit STAAR Surgical Company|STAA - Price to Earnings Multiple|Projected Price to Earnings STAAR Surgical Company|STAA - Company Value to Earnings Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization STAAR Surgical Co|STAA - Operating income before deduction of amortization|Earnings per share for the last twelve months STAAR Surgical|STAA - Net earnings per share for the last four quarters|Year-over-year net earnings per share growth for the last 12 months staar.com|STAA - Net earnings per one share growth for the current year|Earnings growth forecast for next year STAAR Surgical Company
- sales and revenue indicators:
STAA - Revenue and Sales Volume|Projected Sales Volume STAAR Surgical Corp|STAA - P/S Multiple|Price-to-Projected Revenue Ratio STAAR Surgical Co
Summary company analysis:STAAR Surgical Corp (STAA)
Manufactured products of STAAR Surgical

The EV/EBITDA multiple compares the total enterprise value, including net debt, with operating profit before interest, taxes, depreciation, and amortization, allowing for an assessment of the real value of assets regardless of the financing structure. By analyzing changes in the EV/EBITDA multiple, an investor can determine the overvaluation of STAAR Surgical Company (STAA), given that the elective nature of procedures in the US limits pricing power even amidst high demand in Asia.

Competitors of STAAR Surgical Company

Intuitive Surgical Inc - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation DHR|Becton Dickinson & Co - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio steris.com STE|West Pharmaceutical Services, Inc. (WST) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation BAX|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Masimo Personal Health|Stevanato Group Corp (STVN) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio TFX (Teleflex Incorporated)|Enterprise Value to Operating Income Before Depreciation Ratio MMSI|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Envista NVST|Business Value to Operating Income Before Depreciation ICUI|XRAY: Enterprise Value to EBITDA Ratio|LMAT - EV/EBITDA Multiple|AtriCure, Inc. (ATRC) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio ChromaDex|ZIMV (ZimVie) - EV/EBITDA Multiple|Company Value to EBITDA AngioDynamics Inc ANGO|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Cerus Corp (CERS)|Teknova Inc - Enterprise Value to Operating Income Before Depreciation|Monogram Technologies - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio STSS (Sharps Technology Inc)|INFU - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Total Company Value to Operating Income Before Depreciation Ratio Utah Medical Products Inc. UTMD|korumedical.com (KRMD) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|NYXH - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio MBOT|PDEX (pro-dex.com) - Enterprise Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple ZTEK|EV/EBITDA Multiple Elutia Inc (ELUT)|EV/EBITDA Multiple MLSS (Milestone Scientific Corp)|EV/EBITDA Multiple NEXGEL Inc NXGL|RVP - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Business Value to Operating Income Before Depreciation HBIO (Harvard Bioscience Inc.)|FEMY (Femasys) - Enterprise Value to EBITDA Ratio|Meihua Medical Technologies Co., Ltd. - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Predictive Oncology Inc|Callan JMB Corp (CJMB) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio ATRI (Atrion Corporation)|EV/EBITDA Multiple neurometrix.com (NURO)